Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Leggett & Platt Inc T.LEG


Primary Symbol: LEG

Leggett & Platt, Incorporated is a manufacturer that conceives, designs, and produces a range of engineered components and products found in many homes and automobiles. The Company’s segments include Bedding Products, Specialized Products and Furniture, Flooring & Textile Products. Bedding Products segment supplies a variety of components and machinery used by bedding manufacturers in the production and assembly of their finished products, as well as produces private label finished mattresses for bedding brands. Specialized Products segment supplies lumbar support systems, seat suspension systems, motors and actuators, and control cables used by automotive manufacturers. It also produces and distribute tubing and tube assemblies for the aerospace industry and engineered hydraulic cylinders used in the material-handling and construction industries. Furniture, Flooring & Textile Products segment supplies a range of components for residential and work furniture manufacturers.


NYSE:LEG - Post by User

Post by beenburntb4on May 13, 2015 5:04pm
336 Views
Post# 23725810

research comments

research comments
Wednesday, May 13, 2015
 
LGX Oil + Gas Inc. (OIL) Announces First Quarter 2015 Results
In a very quiet quarter of operations that saw the Company only spend $0.7 mm, LGX reported results largely in line with our thinking, albeit framing production and cash flow that retreated from levels in the prior quarter. While there are no meaningful changes to our proforma estimates to alter our current target price of $0.05 per share as a result of this update, the reaffirmation of our Underperform ranking contemplates the real possibility of not being able to meet the financial obligations of its credit facilities and drilling commitments on the Blood Reserve.
<< Previous
Bullboard Posts
Next >>